Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy

MYSM1 deficiency causes inherited bone marrow failure syndrome (IBMFS). We have previously identified an IBMFS patient with a homozygous pathogenic variant in MYSM1 who recovered from cytopenia due to spontaneous correction of one MYSM1 variant in the haematopoietic compartment, an event called somatic genetic rescue (SGR). The study of the genetic and biological aspects of the patient's haematopoietic/lymphopoietic system over a decade after SGR shows that one genetically corrected haematopoietic stem cell (HSC) can restore a healthy and stable haematopoietic system. This supports in vivo gene correction of HSCs as a promising treatment for IBMFS, including MYSM1 deficiency.

Authors

Institutions

Publication Details

Journal
British Journal of Haematology
Published
2024-09-04
DOI
https://doi.org/10.1111/bjh.19744
Citations
5
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
1.20

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy

François Delhommeau, Quentin Riller, Aurore Touzart, Despina Moshous et al.
5 citations
British Journal of Haematology
Immunodeficiency and Autoimmune Disorders
1.20
article

Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy

François Delhommeau, Quentin Riller, Aurore Touzart, Despina Moshous, Patrick Revy, Benoît France, Aude Magérus, Emmanuel Martin, Frédéric Rieux‐Laucat, Aude Echalier, Laëtitia Kermasson, Pierre Hirsch, Sophie de Tocqueville, Alain Fischer
article en
5 citations

Abstract

MYSM1 deficiency causes inherited bone marrow failure syndrome (IBMFS). We have previously identified an IBMFS patient with a homozygous pathogenic variant in MYSM1 who recovered from cytopenia due to spontaneous correction of one MYSM1 variant in the haematopoietic compartment, an event called somatic genetic rescue (SGR). The study of the genetic and biological aspects of the patient's haematopoietic/lymphopoietic system over a decade after SGR shows that one genetically corrected haematopoietic stem cell (HSC) can restore a healthy and stable haematopoietic system. This supports in vivo gene correction of HSCs as a promising treatment for IBMFS, including MYSM1 deficiency.

British Journal of HaematologyVol. 205(6)
Hôpital Necker-Enfants Malades (FR), University of Leicester (GB), Inserm (FR), Université Paris Cité (FR), Université Paris-Saclay (FR), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Centre de Recherche Saint-Antoine (FR), Institute of Structural and Molecular Biology (GB), Institut des Maladies Génétiques Imagine (FR)
Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Institut National Du Cancer
Good health and well-being
Openalex Percentile: Top 21%
Immunodeficiency and Autoimmune Disorders
1.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.